Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes

NCT01647308 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated for business planning purposes. Assessments of APOCIIIRx in this population will be explored in a larger efficacy study

Conditions

Interventions

Sponsor

Ionis Pharmaceuticals, Inc.